Taxation of investments in Stereotaxis, Inc. (NYSE: STXS) follows standard federal, state, and international tax regulations governing equities traded on U.S. public exchanges. When an investor sells shares held in a taxable brokerage account for a profit, the gains are classified as either short-term or long-term capital gains depending on whether the holding period exceeded twelve months. Any cash dividends distributed by the company—though micro-cap medical device enterprises rarely issue dividends while prioritizing research and commercial expansion capital—would be taxed according to qualified or ordinary income tax brackets. Investors should consult professional tax advisors to evaluate how portfolio losses or gains interact with their overall tax filing status.